JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wong, A.
Right arrow Articles by Stadel, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wong, A.
Right arrow Articles by Stadel, J. M.

Vol. 285, Issue 1, 228-235, April 1998

Binding of [3H]-SK&F 107260 and [3H]-SB 214857 to Purified Integrin alpha IIbbeta 3: Evidence for a Common Binding Site for Cyclic Arginyl-Glycinyl-Aspartic Acid Peptides and Nonpeptides

Angela Wong, Shing Mei Hwang, Kyung Johanson, James Samanen, Donald Bennett, Scott W. Landvatter, Wenting Chen, J. Richard Heys, Fadia E. Ali, Thomas W. Ku, William Bondinell, Andrew J. Nichols, David A. Powers and Jeffrey M. Stadel

Departments of Cellular Biochemistry (A. W., S. M. H.), Protein Biochemistry (K. J.), Macromolecular Sciences (D. B.), Synthetic Chemistry (S. W. L., W. C., J. R. H.), Medicinal Chemistry (J. S., F. A., T. W. K., W. B.), and Pharmacology (A. J. N., D. A. P., J. M. S.), SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania

The aggregation of activated platelets is mediated by the binding of fibrinogen to its cell surface receptor, the integrin alpha IIbbeta 3. The recognition of fibrinogen by alpha IIbbeta 3 depends, in part, on the tripeptide sequence Arg-Gly-Asp (RGD) in the adhesive protein. The interactions of a cyclic RGD-containing pentapeptide, [3H]-SK&F-107260, and a 1,4-benzodiazepine-based nonpeptide [3H]-SB-214857, with purified alpha IIbbeta 3 have been investigated. Both compounds potently inhibit platelet aggregation at submicromolar concentrations. Binding of both [3H]-SK&F-107260 (Kd = 1.19 nM) and [3H]-SB-214857 (Kd = 1.85 nM) to alpha IIbbeta 3 is of high affinity and fully reversible. The binding is monophasic, indicating a single class of noncooperative binding sites. The two radioligands exhibited similar values in binding to alpha IIbbeta 3 purified on an RGD-affinity column (Bmax = 0.2 mol/mol alpha IIbbeta 3) or to alpha IIbbeta 3 purified over a lentil lectin column (Bmax = 0.03 mol/mol alpha IIbbeta 3), suggesting that SK&F-107260 and SB-214857 interact with the same population of receptors. Binding of [3H]-SK&F-107260 and [3H]-SB-214857 to alpha IIbbeta 3 require divalent cations, Mg++, Ca++ and Mn++ are able to support binding, with Mn++ being the most effective. Thirteen alpha IIbbeta 3 antagonists, including four linear and three cyclic RGD peptides, five peptidomimetics, the fibrinogen gamma -chain dodecapeptide (HHLGGAKQAGDV) and the snake venom protein, echistatin, complete for [3H]-SK&F-107260 or [3H]-SB-214857 binding to alpha IIbbeta 3. The affinity constants (Ki) of these compounds, determined by the two radioligand binding assays, are similar. Furthermore, these compounds exhibit the same rank order of potency in inhibiting biotinylated-fibrinogen binding to alpha IIbbeta 3. Scatchard plot analyses of the [3H]-SK&F-107260 binding isotherms in the presence of unlabeled SB-214857 and gamma -chain dodecapeptide reveal competitive-type antagonism, indicating that SB-214857, gamma -chain dodecapeptide and SK&F-107260 interact with mutually exclusive binding sites on alpha IIbbeta 3.


0022-3565/98/2851-0228$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.